Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Trent

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
American Journal of Clinical Oncology|January 7, 2020
Low Frequency of Mutation Testing in the United States: An Analysis of 3866 GIST PatientsJorge Florindez, Jonathan Trent
Seminars in Oncology|March 23, 2011
Pharmacokinetics and pharmacodynamics of nilotinib in gastrointestinal stromal tumorsJonathan Trent, Mathieu Molimard
Annual Review of Pharmacology and Toxicology|April 12, 2005
Tyrosine kinase inhibitors and the dawn of molecular cancer therapeuticsRaoul Tibes, Jonathan Trent, Razelle Kurzrock
Current Opinion in Oncology|June 6, 2008
Recent progress in the genomics of soft tissue sarcomasAnthony P Conley, Jonathan Trent, Wei Zhang
Hematology/Oncology Clinics of North America|May 25, 2025
Liposarcoma: Novel Approaches to Systemic Therapy and Multidisciplinary CareEmily Jonczak, Jonathan Trent, Christina Roland, et al.
Journal of Immunotherapy and Precision Oncology|September 10, 2025
Immunotherapy and Targeted Therapies in Sarcoma: Proposed Synergy with Combination TreatmentAleksandra Watson, Gina D'Amato, Emily Jonczak, et al.
Theoretical Population Biology|August 9, 2002
Heterogeneity of genome and proteome content in bacteria, archaea, and eukaryotesSamuel Karlin, Luciano Brocchieri, Jonathan Trent, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 9, 2022
EJSO educational Special issue from the TARPSWG - Standard medical treatment and new options in retroperitoneal sarcomaBernd Kasper, Giacomo Giulio Baldi, Herbert Ho-Fung Loong, et al.
Frontiers in Immunology|September 7, 2021
Beyond the Driver Mutation: Immunotherapies in Gastrointestinal Stromal TumorsMatthieu Roulleaux Dugage, Robin Lewis Jones, Jonathan Trent, et al.
Human Pathology|May 6, 2014
Squamous cell carcinoma arising in dedifferentiated chondrosarcoma proved by isocitrate dehydrogenase mutation analysisYaxia Zhang, Ana Paz Mejia, H Thomas Temple, et al.
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
American Journal of Clinical Oncology|January 7, 2020
Low Frequency of Mutation Testing in the United States: An Analysis of 3866 GIST PatientsJorge Florindez, Jonathan Trent
Seminars in Oncology|March 23, 2011
Pharmacokinetics and pharmacodynamics of nilotinib in gastrointestinal stromal tumorsJonathan Trent, Mathieu Molimard
Annual Review of Pharmacology and Toxicology|April 12, 2005
Tyrosine kinase inhibitors and the dawn of molecular cancer therapeuticsRaoul Tibes, Jonathan Trent, Razelle Kurzrock
Current Opinion in Oncology|June 6, 2008
Recent progress in the genomics of soft tissue sarcomasAnthony P Conley, Jonathan Trent, Wei Zhang
Hematology/Oncology Clinics of North America|May 25, 2025
Liposarcoma: Novel Approaches to Systemic Therapy and Multidisciplinary CareEmily Jonczak, Jonathan Trent, Christina Roland, et al.
Journal of Immunotherapy and Precision Oncology|September 10, 2025
Immunotherapy and Targeted Therapies in Sarcoma: Proposed Synergy with Combination TreatmentAleksandra Watson, Gina D'Amato, Emily Jonczak, et al.
Theoretical Population Biology|August 9, 2002
Heterogeneity of genome and proteome content in bacteria, archaea, and eukaryotesSamuel Karlin, Luciano Brocchieri, Jonathan Trent, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|January 9, 2022
EJSO educational Special issue from the TARPSWG - Standard medical treatment and new options in retroperitoneal sarcomaBernd Kasper, Giacomo Giulio Baldi, Herbert Ho-Fung Loong, et al.
Frontiers in Immunology|September 7, 2021
Beyond the Driver Mutation: Immunotherapies in Gastrointestinal Stromal TumorsMatthieu Roulleaux Dugage, Robin Lewis Jones, Jonathan Trent, et al.
Human Pathology|May 6, 2014
Squamous cell carcinoma arising in dedifferentiated chondrosarcoma proved by isocitrate dehydrogenase mutation analysisYaxia Zhang, Ana Paz Mejia, H Thomas Temple, et al.
Pageof 8